Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 22 tags : Gene therapies save search
Treating the whole body: The case for lentiviral gene therapy’s head-to-toe reach
Published: 2021-04-22 (Crawled : 16:00) - avrobio.com
AVRO | $1.19 -1.65% -1.26% 350K
|
Health Technology
|
| O: 0.36%
H: 5.66%
C: 1.8%
gene therapy therapy gene therapies
Ultragenyx Completes Successful End-of-Phase 2 Meeting with FDA and Finalizes Phase 3 Study Design for DTX301 Ornithine Transcarbamylase (OTC) Gene Therapy ProgramPhase 3 Study on Track to Initiate in Second Half 2021
Published: 2021-04-22 (Crawled : 14:00) - biospace.com/
RARE F | $44.28 -1.84% -1.92% 670K
|
Health Technology
|
| O: 0.39%
H: 2.14%
C: -0.64%
fda phase 2 gene therapy therapy phase 3 gene therapies designation
MediciNova Receives Gene Therapy Milestone Payments
Published: 2021-04-22 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.93%
H: 0.27%
C: 0.17%
MNOV | $1.355 1.88% -3.73% 8K
|
Health Technology
|
| O: 1.11%
H: 1.76%
C: 0.22%
gene therapy therapy gene therapies milestone
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.